BIOQUAL, Inc.
BIOQ
$37.51
-$0.19-0.50%
OTC PK
| 11/30/2025 | 08/31/2025 | 05/31/2025 | 02/28/2025 | 11/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 453.20K | -621.70K | -1.05M | -2.13M | -2.79M |
| Total Depreciation and Amortization | 7.92M | 7.96M | 8.00M | 6.17M | 6.22M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -2.15M | -489.60K | -489.60K | 1.17M | 1.45M |
| Change in Net Operating Assets | -865.80K | -1.48M | -3.52M | -4.50M | -2.58M |
| Cash from Operations | 5.36M | 5.36M | 2.94M | 714.30K | 2.30M |
| Capital Expenditure | -359.80K | -51.20K | -238.80K | -392.90K | -547.90K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -6.12M | -- | -- | -- | -- |
| Cash from Investing | -6.48M | -51.20K | -238.80K | -392.90K | -547.90K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | 0.00 | -447.20K | -447.20K | -447.20K | -447.20K |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 0.00 | -447.20K | -447.20K | -447.20K | -447.20K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1.13M | 4.86M | 2.26M | -125.80K | 1.30M |